Narcolepsy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People diagnosed with Narcolepsy Type 1 or Idiopathic Hypersomnia (a condition causing excessive daytime sleepiness), or healthy people who do not have any sleep disorders
- People who are comfortable using a smartphone on a regular basis
Who may not be able to join:
- People who have moderate or severe sleep apnea that is not being treated
- People who have cognitive (thinking or memory) difficulties that would make it hard to follow the study's requirements (confirm with trial site)
- People whose current medication is not stable, or who are taking sodium oxybate (a specific sleep disorder medication)
- People who have a medical or psychiatric (mental health) condition that is currently unstable or not well controlled
- People who work shift work (irregular or rotating work hours, especially overnight)
- People who are pregnant or currently breastfeeding
- People who have diabetes
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Laure PETER-DEREX, MD-PhD, Hospices Civils de Lyon
Phone: +33 472071929
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
impact of glycaemic load on sleepiness 2 hours after lunch
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.